What is a common symptom of fetal/neonatal benzodiazepine withdrawal?

What is a common symptom of fetal/neonatal benzodiazepine withdrawal?

• A. Hyperactivity
• B. Hyperreflexia
• C. Hypotonia
• D. Inactivity

Answer: (B)

Hyperreflexia is indeed a common symptom observed in fetal or neonatal benzodiazepine withdrawal. This condition occurs when infants are exposed to benzodiazepines in utero, leading to neurodevelopmental effects after birth. Hyperreflexia involves exaggerated reflex responses, which can indicate increased neurological excitability. This symptom stems from the central nervous system's adaptation to the presence of the drug and its subsequent withdrawal. In the context of fetal/neonatal withdrawal, hyperreflexia can be coupled with other signs such as irritability, tremors, and feeding difficulties. Recognizing hyperreflexia among these symptoms is essential for healthcare providers when assessing and managing withdrawal in newborns. The presence of this symptom signifies an alteration in the infant's neurological status due to the abrupt change in benzodiazepine levels following birth.

Hyperreflexia is indeed a common symptom observed in fetal or neonatal benzodiazepine withdrawal. This condition occurs when infants are exposed to benzodiazepines in utero, leading to neurodevelopmental effects after birth. Hyperreflexia involves exaggerated reflex responses, which can indicate increased neurological excitability. This symptom stems from the central nervous system's adaptation to the presence of the drug and its subsequent withdrawal.

In the context of fetal/neonatal withdrawal, hyperreflexia can be coupled with other signs such as irritability, tremors, and feeding difficulties. Recognizing hyperreflexia among these symptoms is essential for healthcare providers when assessing and managing withdrawal in newborns. The presence of this symptom signifies an alteration in the infant's neurological status due to the abrupt change in benzodiazepine levels following birth.